The role of ADCC effector function in the anti-tumor efficacy of anti-EGFR antibodies in a mouse xenograft model.

被引：0
|
作者：
Lo, KM [1 ]
Lan, Y [1 ]
Zhang, X [1 ]
Gillies, SD [1 ]
机构：
[1] EMD Lexigen Res Ctr, Billerica, MA USA
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6099S / 6099S
页数：1
相关论文
共 50 条
  • [31] Lymphangiogenesis augments the anti-tumor efficacy of radiotherapy in mouse melanoma
    Mitrousis, Nikolaos
    Sasso, Maria Stella
    Weichselbaum, Ralph R.
    Hubbell, Jeffrey A.
    Swartz, Melody A.
    CANCER RESEARCH, 2020, 80 (16)
  • [32] Systemic Chemotherapy for Inoperable Goblet Cell Adenocarcinomas (GCAs) and the Role of Anti-EGFR Antibodies
    Barriuso, J.
    Martin, A.
    Chakrabarty, B.
    Burghel, G.
    Lamarca, A.
    Kamposioras, K.
    McNamara, M.
    Clouston, H.
    Hubner, R.
    O'Dwyer, S.
    Wallace, A.
    Valle, J. W.
    NEUROENDOCRINOLOGY, 2020, 110 : 181 - 181
  • [33] Acquisition of terminal effector functions in vitro impairs in vivo anti-tumor efficacy
    Gaittinoni, L
    Klebanoff, CA
    Palmer, DC
    Wrzesinski, C
    Kerstann, K
    Yu, ZY
    Finkelstein, SE
    Surman, DR
    Restifo, NP
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S2 - S2
  • [34] Impact of genetic profiles on the efficacy of anti-EGFR antibodies in metastatic colorectal cancer with KRAS mutation
    Kishiki, Tomokazu
    Ohnishi, Hiroaki
    Masaki, Tadahiko
    Ohtsuka, Kouki
    Ohkura, Yasuo
    Furuse, Jyunji
    Sugiyama, Masanori
    Watanabe, Takashi
    ONCOLOGY REPORTS, 2014, 32 (01) : 57 - 64
  • [35] Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma
    Kim, Jae Hoon
    Shin, Won-Sik
    Lee, Se-Ra
    Kim, Sanggil
    Choi, So-Young
    Lee, Seung-Taek
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [36] In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin
    Zhou, Xikun
    Qiu, Ji
    Wang, Zhen
    Huang, Nongyu
    Li, Xiaolei
    Li, Qian
    Zhang, Yinbing
    Zhao, Chengjian
    Luo, Can
    Zhang, Nannan
    Teng, Xiu
    Chen, Zhongwen
    Liu, Xiao
    Yu, Xianlian
    Wu, Wenling
    Wei, Yu-quan
    Li, Jiong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (07) : 1081 - 1090
  • [37] Enhancing anti-tumor activity against glioblastoma and neuroblastoma by retargeting T cells with OKT3 x anti-EGFR
    Olson, SD
    Davol, PA
    Lum, LG
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S4 - S4
  • [38] In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin
    Xikun Zhou
    Ji Qiu
    Zhen Wang
    Nongyu Huang
    Xiaolei Li
    Qian Li
    Yinbing Zhang
    Chengjian Zhao
    Can Luo
    Nannan Zhang
    Xiu Teng
    Zhongwen Chen
    Xiao Liu
    Xianlian Yu
    Wenling Wu
    Yu-quan Wei
    Jiong Li
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1081 - 1090
  • [39] Role of homeostatic MHC class I recognition in regulating anti-tumor effector function of NK cells
    He, Ka
    Yamamae, Yui
    Sasaki, Soichiro
    Tahara, Hideaki
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2023, 114 : 812 - 812
  • [40] Role of homeostatic MHC class I recognition in regulating anti-tumor effector function of NK cells
    He, Ka
    Yamamae, Yui
    Sasaki, Soichiro
    Tahara, Hideaki
    Hayakawa, Yoshihiro
    CANCER SCIENCE, 2023, 114 : 1163 - 1163
12345